Form 10-Q Akers Biosciences Inc For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Akers Biosciences (AKER) Reports Q3 GAAP Loss of $0.23/Share
November 13, 2014 7:47 AM ESTAkers Biosciences (NASDAQ: AKER) reported Q3 EPS of ($0.23), versus ($0.30) reported last year. Revenue for the quarter came in at $453.3 million, versus $344.7 million reported last year.
The Street was looking for a Q3 loss of $0.17 per share (one estimate).
For earnings history and earnings-related data on Akers Biosciences (AKER) click here.
... More